v3.25.1
Condensed Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Revenues $ 197
Cost of revenues 94
Gross profit 103
Operating expenses:    
Research and development 1,642 1,257
Selling, general and administrative 1,571 1,219
Total operating expenses 3,213 2,476
Loss from operations (3,110) (2,476)
Other income:    
Interest and dividend income 106 37
Change in fair value of common warrant liability 584 1,363
Total other income 690 1,400
Net loss $ (2,420) $ (1,076)
Net loss per share, basic $ (0.08) $ (0.07)
Net loss per share, diluted $ (0.08) $ (0.07)
Weighted-average shares of common stock outstanding, basic 31,395,888 14,947,500
Weighted-average shares of common stock outstanding, diluted 31,395,888 14,947,500

Source